Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy

ClinicalTrials.gov ID: NCT05059223

Public ClinicalTrials.gov record NCT05059223. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 11:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multi- Center Study to Assess the Efficacy and Safety of AXS-12 in the Treatment of Cataplexy and Excessive Daytime Sleepiness in Subjects With Narcolepsy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is a multi-center, double-blind, placebo-controlled, randomized Phase 3 trial to assess the safety and efficacy of AXS-12 in narcoleptic subjects with cataplexy and excessive daytime sleepiness (EDS).

Study identification

NCT ID
NCT05059223
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
90 participants

Conditions and interventions

Eligibility (public fields only)

Age range
15 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 15, 2021 (Actual)
Primary completion
Mar 15, 2024 (Actual)
Completion
Mar 15, 2024 (Actual)
Last update posted
May 28, 2026

2021 – 2024

United States locations

U.S. sites
47
U.S. states
22
U.S. cities
46
Facility City State ZIP Site status
Clinical Research Site Alabaster Alabama 35007 —
Clinical Research Site Peoria Arizona 85381 —
Clinical Research Site Phoenix Arizona 85054 —
Clinical Research Site Redwood City California 94063 —
Clinical Research Site San Diego California 92103 —
Clinical Research Site Santa Ana California 92705 —
Clinical Research Site Santa Monica California 90404 —
Clinical Research Site Boulder Colorado 80301 —
Clinical Research Site Colorado Springs Colorado 80918 —
Clinical Research Site Brandon Florida 33511 —
Clinical Research Site Clearwater Florida 33765 —
Clinical Research Site Doral Florida 33122 —
Clinical Research Site Kissimmee Florida 34741 —
Clinical Research Site Miami Florida 33176 —
Clinical Research Site Miami Lakes Florida 33016 —
Clinical Research Site St. Petersburg Florida 33707 —
Clinical Research Site Tampa Florida 33634 —
Clinical Research Site Winter Park Florida 32789 —
Clinical Research Site Atlanta Georgia 30315 —
Clinical Research Site Atlanta Georgia 30328 —
Clinical Research Site Gainesville Georgia 30501 —
Clinical Research Site Macon Georgia 31210 —
Clinical Research Site Stockbridge Georgia 30281 —
Clinical Research Site Honolulu Hawaii 96817 —
Clinical Research Site Peoria Illinois 61637 —
Clinical Research Site Fort Wayne Indiana 46804 —
Clinical Research Site Chevy Chase Maryland 20815 —
Clinical Research Site Newton Massachusetts 02459 —
Clinical Research Site North Dartmouth Massachusetts 02747 —
Clinical Research Site Kalamazoo Michigan 49008 —
Clinical Research Site Novi Michigan 48377 —
Clinical Research Site St Louis Missouri 63123 —
Clinical Research Site Las Vegas Nevada 89106 —
Clinical Research Site Neptune City New Jersey 07753 —
Clinical Research Site Brooklyn New York 11230 —
Clinical Research Site New Hyde Park New York 11040 —
Clinical Research Site Denver North Carolina 28037 —
Clinical Research Site Gastonia North Carolina 28054 —
Clinical Research Site Huntersville North Carolina 28078 —
Clinical Research Site Cincinnati Ohio 45245 —
Clinical Research Site Wyomissing Pennsylvania 19610 —
Clinical Research Site Charleston South Carolina 29425 —
Clinical Research Site Columbia South Carolina 29201 —
Clinical Research Site Austin Texas 78731 —
Clinical Research Site San Antonio Texas 78229 —
Clinical Research Site Sugar Land Texas 77478 —
Clinical Research Site Williamsburg Virginia 23188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05059223, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2026 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05059223 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →